If you have children, surely “the Dalsy” is part of your medicine cabinet and has gotten you out of more than one bind. Now, Viatris, the laboratory that markets it, launches Dalsydol, the Dalsy extension, for adults and adolescents from 12 years (weight over 40 kg), which relieves occasional mild or moderate pain, such as headache, back, muscle, menstrual or dental pain, in addition to relieving fever.
After more than 30 years of experience in the market with Dalsy, the pharmaceutical company launches this new version of the medicine, a brand of ibuprofen for sale in pharmacies without a prescription. Ibuprofen is an anti-inflammatory analgesic medication suitable for occasional pain and fever, administered orally. The white, plain tablets without inscriptions or scores contain a 400 mg dose of ibuprofen. Therefore, the daily amount of 1,200 mg of ibuprofen should not be exceeded, that is, three tablets. It can be consumed every 6-8 hours, with or just after meals, and should always be swallowed whole, without chewing, breaking, crushing or sucking, to avoid mouth discomfort or throat irritation.
The drug is for occasional use and should be administered for short periods of time. In the case of people over 65 years of age, it will be the doctor who indicates the usual dose, since this may be reduced. On the other hand, those Patients with renal, hepatic or cardiac insufficiency should also consult their doctor before to take Dalsydol. In the case of healthy patients, if after taking Dalsydol for more than 5 days (in the case of adults) or more than 3 days (in the case of adolescents) the pain persists, the fever worsens or new symptoms appear, it should be Consult a doctor to assess the clinical situation.
The incidence of pain
According to the World Health Organization (WHO), pain is the main threat to people’s quality of life. Occasional pain has a direct impact on the normal development of daily activities, thus affecting their well-being. According to a 2021 study by Kantar, 94% of Spaniards have suffered from it occasionally in the last 6 months. The study data reveals that 88% of people (approximately 9 out of 10) trust the efficacy and safety of analgesics to combat occasional pain. In addition, 51% consider ibuprofen more effective for symptom relief and almost 7 out of 10 people prefer ibuprofen as an anti-inflammatory.